Literature DB >> 4401704

A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man.

E M Phillips, M Woolnough, V M Marinova, P Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401704     DOI: 10.1002/j.1552-4604.1972.tb00045.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN: 0021-9754


× No keyword cloud information.
  7 in total

1.  Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.

Authors:  G E Marlin; B J Hartnett; N Berend
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 2.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

3.  Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Authors:  G E Marlin; B J Hartnett; N Berend; N B Hacket
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

4.  Pharmacological screening of new chemical entities in human subjects and methods of data handling.

Authors:  T J Sullivan; A R Croft; R Hanka; S J Roberts
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

5.  Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.

Authors:  G E Marlin; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

6.  Response to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  N J Cooke; J A Kerr; R F Willey; M V Hoare; I W Grant; G K Cromptom
Journal:  Br Med J       Date:  1974-05-04

7.  A new bronchodilator, rimiterol hydrobromide (R 798): An open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients.

Authors:  W D Linehan
Journal:  Ir J Med Sci       Date:  1975-12       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.